The Air Force Health Study (AFHS), also called the Ranch Hand Study, investigated the impact of exposure to dioxin the toxic contaminant in Agent Orange on health, survival, and reproductive outcomes of male Air Force Vietnam War veterans. It was concluded that available reproductive outcome data did not provide support for an adverse association with paternal dioxin exposure. A more extensive set of AFHS data was used to reassess this conclusion, restricting to the case of birth defects in children fathered after the start of the first Vietnam War tour. Analyses started by repeating published analyses, followed by assessing decisions made in those analyses, for example, of excluding participants with dioxin levels below the detectable limit, using a threshold of 10 parts per trillion for a high dioxin level, and not adjusting for multiple conceptions/children of the same participant. Using data for all participants with measured dioxin levels, both veterans who served in Operation Ranch Hand and other non-Ranch Hand veterans, and after accounting for correlation within children of the same participant, the occurrence for children fathered after the start of the first tour of a major defect, a non-major defect, and multiple defects depended significantly on participants having a high dioxin level. These conclusions were not changed by consideration of covariates. In contrast to prior published analyses, the more extensive AFHS data provided support for an adverse effect of paternal dioxin exposure on birth defects. However, the study had many limitations that could have affected the conclusions.
Medical records were reviewed to verify reproductive outcomes. Participants' serum dioxin levels were also collected for use as a measure of herbicide exposure. By 1992, the medical record review had progressed to the point that an official report on reproductive outcomes was issued [3] . Medical records, including birth certificates, newborn clinic records, health records, and death certificates, were reviewed for all children, not just those self-reported by parents as having defects/disabilities, to avoid reporting bias. They also evaluated the possibility of differential reporting due to Ranch Hand participants seeking medical evaluation for birth defects more than the other veterans, thereby making their children's birth defects more verifiable, especially in births conceived after the start of the first tour. No evidence of such a verification bias was found. It was concluded that data verified by that time did not provide support for an adverse association of paternal dioxin exposure on reproductive outcomes. Results from the 1992 report were published in 1995 [4] , drawing the same conclusion of no adverse association. See [5] for more details on the study.
Ranch Hand Study data were released in 2000 to the Vietnam Veterans of
America with some secondary analysis results reported at a conference in 2003 [6] . These data were used to conduct a new set of secondary analyses. The objective of these latest analyses was to reassess the dependence of birth defects in the children of AFHS participants on dioxin exposure, starting from prior published AFHS analyses [4] .
Methods

Birth Defect Data
Data were available for 6922 live-born children with known conception date ( Table 1) that were fathered by 2613 AFHS participants (Table 2) . Birth defects were verified through medical records and categorized into major, minor, and unclassified (Table 3) . Dioxin levels were measured for 2038 (78.0%) participants with values either ranging from 1.25 to 314.2 parts per trillion (ppt) or below the detection limit for 115 (5.6%) of these participants (treated as ≤ 1 ppt).
The 1160 participants with measured dioxin levels fathered 2188 children after the start of their first tour of duty during the Vietnam War (Table 4) . Their Mothers smoked for 17.8% of these pregnancies and drank for 6.3%. Median age at birth for mothers was 27 years and 30 years for fathers. Only the mother's age had missing values with ages missing for 1.2% of the children.
Published Analyses Conducted by the AFHS
Wolfe et al. [4] reported results on reproductive outcome data available at that time for participants with measured dioxin levels. They considered only conceptions that occurred after the start of the first tour. They treated dioxin levels at or below 10 ppt as background exposures. They excluded data for non-Ranch Hand participants with dioxin levels greater than 10 ppt and categorized Ranch Hand participants into those with dioxin ≤ 10 versus > 10. They also excluded participants with dioxin levels below the detectable limit. This left data for 2241 pregnancies, 1773 children, and 1024 participants. Although many participants fathered multiple conceptions/children, these published analyses did not account for possible correlation within outcome values for conceptions/children of the same participant. The dioxin > 10 category was further categorized on the basis of low/high values for an estimate of the dioxin exposure at the time of conception, but that issue was not considered here.
Data Analysis
Reported analyses started by rerunning published analyses using currently available data, but only for birth defects and not for other reproductive outcomes. Then, several sensitivity analyses were conducted including assessing the effect of excluding participants with dioxin values below the detectable limit, of Ranch Hand and non-Ranch Hand participants and comparisons to birth defects for children conceived before the start of the tour were also addressed.
Analyses modeled the occurrence of birth defect outcomes using logistic regression models. To account for correlation within outcomes for children of the same participant, analyses used generalized estimating equations (GEE) techniques assuming an exchangeable correlation structure with the correlation the same for all pairs of children of the same participant. Three birth defect outcomes were considered: the occurrence of a major defect compared to a non-major (minor or unclassified) or no defect, of multiple (>1) defects compared to one or no defect, and of a non-major defect compared to no defect after removing children born with a major defect. Wald χ 2 tests for zero coefficients based on empirical standard error estimates were generated for these models.
Standard χ 2 tests were generated for analyses reproducing published results. Significance was set at p < 0.05.
Alternate models for the occurrence of the three birth defect outcomes were compared using adaptive regression methods [7] . Models were evaluated using 10-fold extended likelihood cross-validation (LCV + ) scores based on the multivariate normal likelihood evaluated at Pearson residuals as defined and justified in [7] . The data were randomly partitioned into 10 disjoint subsets or folds. The extended likelihood for each fold was computed using the fold data and parameters estimated using data in the other folds. These deleted fold extended likelihoods were combined into an LCV + score with a higher value indicating a better model. Thresholds for high dioxin levels were adaptively identified using grid searches maximizing the LCV + score. These searches first considered alternative thresholds that were multiples of 0.5, then multiples of 0.1 around the multiple of 0.5 generating the best LCV + score. Although generated thresholds maximized the LCV + score, the associated threshold effect was not guaranteed to be significant.
Reported analyses were generated using SAS  version 9.4 (SAS Institute, Inc., Cary, NC). SAS macros are available from the author for computing LCV + scores for GEE models (and more general regression models as well) and for searching through alternate thresholds for a high dioxin level. Code generating reported results as well as generated output are also available.
Results
Rerunning Published Analyses Conducted by the Air Force Health Study
Of the 2188 children born after the start of the first tour for fathers with measured dioxin levels (Table 5) , excluding children for participants with dioxin levels below the detection limit removes 130 children (5.9%). Excluding children (100) 2188 (100) 2032 (100) ppt-parts per trillion.
for non-Ranch Hand participants with dioxin > 10 removes 26 (1.2%) more children, leaving 2032 children (92.9%). Of these children, 1135 (55.9%) were born to non-Ranch Hand participants with 1 < dioxin ≤ 10, 342 (16.8%) to Ranch Hand participants with 1 < dioxin ≤ 10, and 555 (27.3%) to Ranch Hand participants with dioxin > 10. Corresponding percentages for published analyses were similar at 55.3%, 16.0%, and 28.7% out of 1773 children [4] . Of the 2032 children, 125 (6.2%) had a major defect and 77 (3.8%) had multiple defects. Of the remaining 1907 children without major defects, 316 (16.6%) had a non-major (minor or unclassified) defect. Using standard χ 2 tests, participant-dioxin exposure type (non-Ranch Hand, 1 < dioxin ≤ 10; Ranch Hand, 1 < dioxin ≤ 10; Ranch Hand, dioxin > 10) was not significantly related to having a major defect (p = 0.074), to having multiple defects (p = 0.144), and to having a non-major defect compared to no defect (p = 0.927). These conclusions were consistent with those reported by Wolfe et al. [4] .
Impact of Excluding Participants
Including the 130 children for participants with dioxin levels below the detectable limit (≤1) increases the number of children to 2162 with 129 (6.0%) having a major defect and 79 (3.7%) having multiple defects. Of the 2033 children without major defects, 334 (16.4%) had a non-major defect.
Using standard χ 2 tests, participant-dioxin exposure type (non-Ranch Hand, dioxin ≤ 10; Ranch Hand, dioxin ≤ 10; Ranch Hand, dioxin > 10) was not significantly related to having multiple defects (p = 0.103) and to having a non-major defect compared to no defect (p = 0.943), but was now significantly related to having a major defect (p = 0.043). Children of Ranch Hand participants with dioxin > 10 were more likely to have a major defect than children for non-Ranch Hand participants and Ranch Hand participants having dioxin ≤ 10 (8.1% versus 5.1% and 5.7%).
Of the 26 non-Ranch Hand participants with dioxin > 10, 3 (11.5%) had a major defect. This result combined with the prior result suggested that the oc- 
Occurrence of Birth Defects in Children of Participants with Measured Dioxin Levels
The 1160 participants with measured dioxin levels fathered 1 -10 children after the start of the first tour. Of these participants, 1038 (89.5%), 113 (9.7%), 8
(0.7%), and 1 (0.1%) had 0, 1, 2, and 3 children with a major defect, respectively; 1083 (93.4%), 75 (6.5%), and 2 (0.2%) had 0, 1, and 2 children with multiple defects (2 -5 defects per child), respectively; 292 (25.2%) had dioxin > 10. These participants fathered 2,188 children after the start of the first tour with 132 (6.0%) having a major defect and 79 (3.6%) with multiple defects.
For the 1130 participants fathering children with non-major or no defects, 847
(75.0%), 234 (20.7%), 45 (4.0%), and 4 (0.4%) had 0, 1, 2, and 3 children with a non-major defect, respectively; 282 (25.0%) had dioxin > 10. These participants fathered 2,056 children after the start of the first tour with 336 (16.3%) having a non-major defect.
Using GEE techniques to account for within-participant correlation (as for all subsequent analyses), the occurrence of a major defect was significantly related to having dioxin > 10 versus dioxin ≤ 10 (p = 0.009; estimated mean 0.083 versus 0.052; OR 1.65, 95% CI 1.13 -2.41) while the occurrence of multiple defects was non-significant (p = 0.066). Excluding participants with children having major defects, the occurrence of a non-major defect compared to no defect was not significantly related to having dioxin > 10 versus dioxin ≤ 10 (p = 0.807). Table 6 presents results for adaptive selection of thresholds for a high dioxin level. Three outcomes were considered: the occurrence of a major defect versus a non-major or no defect, of multiple defects versus 1 or no defect, and of a non-major defect versus no defect.
Adaptive Generation of Thresholds for a High Dioxin Level
A grid search identified that the threshold of 6.3 maximized the LCV + score for predicting the occurrence of a major defect. The occurrence of a major defect was significantly related to having dioxin > 6.3 versus dioxin ≤ 6.3 (p < 0.001) with estimated probability of a major defect 0.085 versus 0.045.
A grid search identified that the threshold of 8.8 maximized the LCV + score for predicting the occurrence of multiple defects. The occurrence of multiple defects was significantly related to having dioxin > 8.8 versus dioxin ≤ 8.8 (p = 0.012) with estimated probability of a multiple defects 0.052 versus 0.030.
A grid search identified that the threshold of 3.7 maximized the LCV + score Open Journal of Epidemiology for predicting the occurrence of a non-major defect (compared to no defects).
The occurrence of a non-major defect was significantly related to having dioxin > 3.7 versus dioxin ≤ 3.7 (p = 0.034) with estimated probability of a non-major defect 0.176 versus 0.137.
Differences for Ranch Hand Participants
The AFHS surveyed non-Ranch Hand participants to constitute a comparison group to the Ranch Hand participants. The Ranch Hand participants do represent a high dioxin group with dioxin values ranging from undetected to 314.2 ppt with median 13.6 ppt compared to values for non-Ranch hand participants ranging from undetected to 54.8 ppt with median 3.6 ppt. However, Ranch Hand participants were not significantly more likely than non-Ranch
Hand participants to have children with a major defect (p = 0.059), with multiple defects (p = 0.312), and with a non-major versus no defect (p = 0.926). After controlling for a high dioxin level (varying with the outcome), being a Ranch
Hand participant, and their interaction, the interaction had a non-significant effect on the occurrence of multiple defects (p = 0.907) and the occurrence of a non-major versus no defect (p = 0.197). The interaction had a significant (p = 0.024) effect on the occurrence of a major defect, but the estimated probability of a major defect was larger for non-Ranch Hand participants with a high dioxin level than Ranch Hand participants with a high dioxin level (0.129 versus 0.075).
Impact of Missing Dioxin Levels
Of 1497 participants who fathered 2742 children after the start of their tours, dioxin levels were missing for 337 (22.5%) participants who fathered 554 (20.3%) children after the start of the first tour (Table 1 & Table 2 ). Data for The participant having a missing dioxin level had a non-significant effect on the occurrence of a major defect (p = 0.060) and on the occurrence of multiple defects (p = 0.402), but had a significant effect on the occurrence of a non-major versus no defect (p < 0.001). The estimated probability of having a non-major versus no defect was lower for children fathered by participants with a missing dioxin level (0.097 compared to 0.163).
Comparison to Children Conceived Prior to the Start of the First Tour for Participants with Measured Dioxin Levels
A total of 5478 children were fathered either before or after the start of the first tour by 2038 participants with measured dioxin levels. These participants fathered from 1 -11 children. Models were considered for birth defect outcomes for these children including two effects: 1) being conceived after the start of the first tour for participants having a high dioxin level (adjusted for the outcome) and; 2) being conceived before the start of the first tour. In this way, birth defect outcomes for children conceived before the start of the first tour are compared to birth defect outcomes for children conceived after the start of the first tour for participants having a low/background dioxin level.
The estimated probability of a child having a major defect when born before the start of the first tour was not significantly different from the estimated probability of a child having a major defect when born after the start of the first tour for a participant having a low/background dioxin level (p = 0.283). The estimated probability of a child having multiple defects when born before the start of the first tour was significantly lower than the estimated probability of a child having a major defect when born after the start of the first tour for a participant having a low/background dioxin level (p = 0.005, estimated probability 0.017 versus 0.030). In both cases, the effect to being conceived after the start of the first tour for participants having a high dioxin level remained significant (p < 0.05) with larger estimated probability.
A total of 5222 children without a major defect were fathered either before or after the start of the first tour by 2017 participants with measured dioxin levels. These participants fathered from 1 -11 children. The estimated probability of a child having a non-major defect was significantly lower when born before the start of the first tour than when born after the start of the first tour for a participant having a low/background dioxin level (p < 0.001, estimated probability 0.077 versus 0.138). The effect to being conceived after the start of the first tour for participants having a high dioxin level remained significant (p < 0.05) with larger estimated probability.
Adjusting for Covariates
Wolfe et al. [4] considered seven covariates including whether the mother Open Journal of Epidemiology smoked or not and drank or not during the pregnancy, the age of the mother and of the father at the birth of the child, and whether the father was Black or not, an officer or not, and a flyer or not. See Table 4 for descriptive statistics for these covariates.
Covariate analyses were conducted for the three birth defect outcomes considered earlier for children fathered after the start of the tour by participants with measured dioxin levels. To assess the impact of a covariate on the conclusion of an effect to a high dioxin level on each outcome, the covariate was added to the model for that outcome based on the associated indicator for a high dioxin level.
After controlling for the effect of a high dioxin level (>6.3), the occurrence of a major defect did not depend significantly (p > 0.05) on each of five covariates separately while the effect of a high dioxin level remained significant (p < 0.001).
The two exceptions with a significant effect were for the participant age at birth (p = 0.013) and for Black participants (0.039), but in both cases the effect to a high dioxin level remained significant (p < 0.001). Further, when both of these two covariate effects were included in the model, both remained significant (increasing with participant age, p = 0.014; decreasing for Black participants, p = 0.039) as also did the effect of a high dioxin level (p < 0.001).
After controlling for the effect of a high dioxin level (>8.8), the occurrence of multiple defects did not depend significantly (p > 0.05) on each of the seven covariates separately. The effect of a high dioxin level remained significant (p < 0.05) in all cases.
After controlling for the effect of a high dioxin level (>3.7), the occurrence of a non-major versus no defect did not depend significantly (p > 0.05) on each of the seven covariates separately. The effect of a high dioxin level remained significant (p < 0.05) in all cases.
Discussion
Three birth defect outcomes were considered: having a major defect versus a non-major (minor or unclassified) or no defect, having multiple defects (>1) versus one or no defect, and, after removing children with a major defect, having a non-major defect versus no defect. When published analyses [4] were rerun addressing the occurrence of these three birth defect outcomes in children fathered after the start of the first tour using the more extensive AFHS data set, the same conclusion of no significant effect to participant-dioxin exposure type (non-Ranch Hand, 1 < dioxin ≤ 10; Ranch Hand, 1 < dioxin ≤ 10; Ranch Hand, dioxin > 10) held in all three cases. After including birth defect data for participants with dioxin values below the detectable limit (≤1), the effect of participant-dioxin exposure type on the occurrence of multiple defects and of a non-major defect remained non-significant, but its effect on the occurrence of a major defect became significant. The proportion of children with a major defect for non-Ranch AFHS participants with measured dioxin levels fathered from 1 -10 children after the start of the first tour. The occurrence of birth defects in children for the same father would likely be correlated, so prior reported analyses were limited by not adjusting for this issue as were prior published analyses. This limitation was avoided by modeling correlations between birth defect outcomes for pairs of children for the same participant using GEE techniques. After adjusting for this correlation, having a high dioxin level (>10, as used in published analyses) was significantly related to an increased probability of a major defect but not of multiple defects or of a non-major defect.
Using adaptive methods [7] (Table 6) , alternate thresholds for a high dioxin level were identified for modeling the three birth defect outcomes for children conceived after the start of the first Vietnam War tour. Having a high dioxin level was significantly related to a larger estimated probability for children conceived after the start of the first tour in all three cases of having a major defect (dioxin > 6.3), multiple defects (dioxin > 8.8), and a non-major defect (dioxin > 3.7). Consequently, the conclusion of no effect to dioxin on birth defect outcomes in published analyses was a consequence of the combination of using a smaller data set, excluding selected sets of children, not adjusting for correlation within children of the same participant, and most importantly using a fixed level as a threshold for a high dioxin level (dioxin > 10). The opposite conclusion of an adverse effect of paternal dioxin exposure on birth defects held when these limitations were resolved as well as after controlling for the same covariates considered in prior published analyses [4] .
Sensitivity analyses suggested that it was not necessary to distinguish between Ranch Hand and non-Ranch Hand participants. This suggests that identified adverse effects to high dioxin levels are reasonably treated as holding equally for both groups of participants.
Children conceived before the start of the first tour for all participants with measured dioxin levels were not significantly less likely to have a major defect then children conceived after that for participants with low/background dioxin levels, but were significantly less likely to have multiple defects or to have non-major defect. In all three cases, children conceived after the start of the first tour to participants with high dioxin levels were still significantly more likely to have the associated birth defect type. Consequently, children born before the start of the first tour were less likely to have two of the three birth defect outcomes than children born after that, indicating that background levels of these outcomes increased from before to after the Vietnam War, but high dioxin levels still had an adverse effect on all three outcomes for children conceived after the start of the first tour for participants with high dioxin levels.
Limitations
Dioxin levels were not measured for substantial numbers of AFHS participants; results might have changed if these dioxin levels had been measured. However, the occurrence of a major defect and of multiple defects was not significantly different for children of participants with missing versus measured dioxin levels, suggesting missing dioxin levels may not have biased results for these two more serious birth defect outcomes. On the other hand, the occurrence of a non-major defect was significantly lower for children of participants with missing dioxin levels compared to participants with measured dioxin levels. This suggests that missing dioxin levels may have biased results for this less serious birth defect outcome unless the actual dioxin levels for these participants were mainly low levels.
Analyses were based on post-exposure serum dioxin levels measured well after participants' tours ended and should be interpreted with this in mind. In particular, selected thresholds for adverse dioxin exposure were most likely smaller due to decay than if exposure had been measured just after the last tour. However, the issue of decay was not addressed in reported analyses as well as the related issue of varying times between the end of the last tour and conceptions.
The possible effect of the combined length of all Vietnam War tours was also not addressed. In any case, as would be expected, the thresholds identified for the three birth defect outcomes increased with the severity of the birth defect type (i.e., 3.7 for as non-major defect, 6.3 for as major defect, and 8.8 for multiple defects).
Reported analyses only addressed three birth defect outcomes. Other reproductive outcomes were available for live-born children, including categories of birth defects (e.g., affecting the respiratory system), developmental disabilities (e.g., hyperkinetic), and birth weight and also for all conceptions (e.g., spontaneous abortion). Future research is needed to address possible adverse dioxin effects on these other outcomes.
This was a secondary analysis of data from a previously conducted study.
What can be addressed was limited by what information was available in those data. For example, the data did not provide information about participants' occupations after service in the Vietnam War, which could account for possible exposures after the end of the last tour. Information was also not available on whether spouses/partners also served in the Vietnam War, which given the results of Kang et al. [8] would be useful for separating maternal from paternal dioxin exposure. It was also possible that Air Force veterans with children having birth defects were more likely to agree to participate in the study. Aschengrau and Monson [10] found an increased, but non-significant level (OR 1.3, 95% CI: 0.9 -1.9) of defects in children of Vietnam veterans compared to children of men without known military service. Ngo et al. [11] concluded on the basis of a meta-analysis that parental exposure to dioxin appears to be associated with increased risk for birth defects. However, Fraser [12] questioned the validity of this meta-analysis. In contrast, the results of the current study provide novel substantive support for an adverse association of birth defects with paternal dioxin exposure. Furthermore, such results are plausible since Mattison [13] concluded on the basis of a literature review that offspring are vulnerable to all endpoints of developmental toxicity, including structural and functional abnormalities, as a consequence of paternal, and not just maternal, exposures to chemicals.
Summary
In conclusion, in contrast to prior published analyses of data from the AFHS, support was identified for an adverse effect to paternal dioxin exposure on birth defects in the children fathered by male Air Force Vietnam veterans after the start of their first Vietnam War tour. This opposite conclusion was the combined result of using a larger data set, not excluding selected participants, adjusting for correlation between outcomes for children of the same participant, and using a threshold for a high dioxin exposure level adaptively set separately for each birth defect outcome. These conclusions still held after adjusting for the same covariates considered in prior published analyses. However, the study had many limitations that could have affected these conclusions.
